Tenet forecasts 2026 adjusted EBITDA of $5.05B-$5.2B as Conifer transition items lift results (NYSE:THC)
Tenet Healthcare (THC) reported Q3 2026 net operating revenues of $5.6B and adjusted EBITDA of $1.355B. CEO Saumya Sutaria noted an 80% increase in adjusted diluted earnings per share to $6.64. The company forecasts 2026 adjusted EBITDA of $5.05B-$5.2B, driven by Conifer transition items.
How this was made
The 30-second read
Why it matters
The disclosed earnings and forward EBITDA guidance provide fresh material for traders to reassess valuation.
Market read
The earnings beat and raised 2026 EBITDA outlook are likely to drive short‑term price movement in THC.
What to watch
Potential headwinds from regulatory changes or payer reimbursement pressures could temper upside.
Background
Tenet Healthcare (NYSE:THC) released its Q3 2026 earnings via an AI‑generated transcript on Seeking Alpha.
Ticker impact
Q3 2026 adjusted EBITDA of $1.355 B and net operating revenues of $5.6 B were disclosed in the earnings call.
potential upside as the market prices in the robust earnings and higher 2026 guidance
The earnings beat and forward‑looking EBITDA range are new material information that can move the stock.
Market effects
Strong performance may lift the broader healthcare services sector.
U.S. hospital and outpatient‑care operators could see increased investor interest.
Limited to U.S. healthcare equities; no direct global macro effect.
Counterpoint
If the guidance is already priced in, the stock may face a pull‑back on profit‑taking.
Key entities
- companyTenet Healthcare Corporation
U.S. healthcare services provider



